首页 › 基金 › BRAIDWELL LP › MBX
BRAIDWELL LP 对 MBX 的持仓历史
MBX BIOSCIENCES INC COM · 医疗保健
BRAIDWELL LP 在 Q2 2026 的 13F 申报中披露持有 MBX(MBX BIOSCIENCES INC COM)710,880 股,市值约 US$39.2M,约占其申报组合的 1.54%,在其申报持仓中市值排名第 24 位。 BRAIDWELL LP 最近 3 个申报季度中有 3 个季度披露了 MBX 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
BRAIDWELL LP 对 MBX 的持仓演变
BRAIDWELL LP 于 Q4 2025 首次披露 MBX 持仓:1,018,600 股(约 US$32.1M)。 该持仓在 Q1 2026 达到峰值 1,492,467 股,市值约 US$44.6M。 在 3 次申报中,BRAIDWELL LP 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 710,880 股、市值约 US$39.2M,环比减持 -781,587 股。。 持仓曾出现大幅变动:Q1 2026 增持约 47% (随后一个季度股价上涨 85%)、Q2 2026 减持约 52% (随后一个季度股价上涨 6%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 1.02M | $32.13M | 新进 |
| Q1 2026 | 1.49M | $44.55M | 增持 |
| Q2 2026 | 710.88K | $39.24M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MBX 与 13F 数据
MBX(MBX BIOSCIENCES INC COM)属于医疗保健行业。我们追踪的基金中还有 73 只申报持有 MBX,申报仓位最大的包括:Frazier Life Sciences Management, L.P. (US$367.2M), NEA Management Company, LLC (US$199.5M), ORBIMED ADVISORS LLC (US$189.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MBX 的基金
- Frazier Life Sciences Management, L.P. 6.65M 股 · $367.19M · Q2 2026
- NEA Management Company, LLC 3.61M 股 · $199.52M · Q2 2026
- ORBIMED ADVISORS LLC 3.43M 股 · $189.27M · Q2 2026
- Paradigm Biocapital Advisors LP 2.51M 股 · $138.44M · Q2 2026
- NVP Associates, LLC 2.14M 股 · $117.93M · Q2 2026
- Deep Track Capital, LP 1.73M 股 · $95.64M · Q2 2026
- Aaron Wealth Advisors LLC 1.18M 股 · $68.92M · Q3 2026
- Kynam Capital Management, LP 934.80K 股 · $51.60M · Q2 2026
- Parkman Healthcare Partners LLC 800.17K 股 · $44.17M · Q2 2026
- TCG Crossover Management, LLC 650.00K 股 · $35.88M · Q2 2026
- Cormorant Asset Management, LP 550.00K 股 · $30.36M · Q2 2026
- Soleus Capital Management, L.P. 515.28K 股 · $28.44M · Q2 2026
更多关于 BRAIDWELL LP
常见问题
How long has BRAIDWELL LP held MBX?
BRAIDWELL LP has disclosed MBX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is BRAIDWELL LP's current position in MBX?
As of Q2 2026, BRAIDWELL LP holds 710.88K shares of MBX (MBX BIOSCIENCES INC COM), valued at $39.24M, representing 1.54% of its reported portfolio and ranking #24.
Has BRAIDWELL LP been buying or selling MBX?
In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in MBX. The position peaked in Q1 2026 at 1.49M shares.
Which other funds hold MBX?
Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., NEA Management Company, LLC, ORBIMED ADVISORS LLC, among 73 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.